On January 14th, a research team from the School of Engineering and Applications at the University of Pennsylvania in the United States developed a new gene editing platform called “Minimum Universal Genetic Perturbation Technology (mvGPT)”. This platform integrates multiple functions such as precise gene editing, gene expression activation and inhibition, providing powerful tools for studying DNA functional principles and treating genetic diseases. The relevant paper was published in the latest issue of the journal Nature Communications.
Scan code to share